ArticleOncology letters2011

Inhibition of p38 MAPK activity in B-NHL Raji cells by treatment with engineered CD20-specific T cells.

Lei Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.